The Structural Disease Center

Filter Your Results

 

News

 

CE Mark Approval Extended for BioVentrix’s Revivent TC LIVE Therapy

January 22, 2020 -- BioVentrix, Inc. announced the extension of European CE Mark approval for its Revivent TC transcatheter ventricular enhancement system for heart failure to…

PREDICT-LAA Trial Enrolls First Patient to Study FEops HeartGuide Computer Simulation Device

January 17, 2020 -- FEops announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. Headquartered in Gent, Belgium, FEops is focused on …

Corvia Medical’s REDUCE LAP-HF II Global Clinical Trial Enrolls First Patients in Japan

January 13, 2020 -- Corvia Medical, Inc. announced commencement of the REDUCE LAP-HF II in Japan under a clinical trial authorization from the Pharmaceutical and Medical Devic…

One-Year Outcomes Published for BioVentrix’s Revivent TC System

December 4, 2019 -- BioVentrix, Inc., developer of a less invasive system for left ventricular remodeling, announced the publication of positive 1-year results from its CE Mar…

Long-Term Data Reported From Continued Access Registries of Boston Scientific’s Watchman LAAC Device

December 2, 2019 -- Findings from continued access registries on the long-term safety and efficacy of the Watchman left atrial appendage closure (LAAC) device (Boston Scientif…

FDA Issues Update on Postapproval Study Findings for Abiomed’s Impella RP System

December 2, 2019 -- The FDA issued an update on data for the Impella RP system (Abiomed, Inc.). The most recent, interim postapproval study (PAS) results for the Impella RP Sy…

BioVentrix’s Revivent TC System Receives FDA Breakthrough Device Designation

November 19, 2019 -- BioVentrix, Inc. announced that the FDA has granted Breakthrough Device designation status for the company’s Revivent TC transcatheter ventricular e…

SIRONA Trial Data Presented for Endotronix’s Cordella PA Pressure Sensor System

November 18, 2019 -- Endotronix announced that data from the SIRONA first-in-human trial for the Cordella pulmonary artery (PA) pressure sensor system were presented by Prof. …

 

advertisement

Top 5 Top 5 In Structural Disease Center

PREDICT-LAA Trial Enrolls First Patient to Study FEops HeartGuide Computer Simulation Device

Corvia Medical’s REDUCE LAP-HF II Global Clinical Trial Enrolls First Patients in Japan

CE Mark Approval Extended for BioVentrix’s Revivent TC LIVE Therapy

 

Centers

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

Other Resources

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.